Unresectable Extrahepatic Bile Duct Cancer Completed Phase 2 Trials for Trastuzumab (DB00072)

IndicationStatusPhase
DBCOND0028791 (Unresectable Extrahepatic Bile Duct Cancer)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs